Evidence map›Paper›PMID 29431694›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses.

Iris Hecht, Amir Toporik, Joseph R Podojil, Ilan Vaknin, Gady Cojocaru, Anat Oren, Elizabeta Aizman, Spencer C Liang, Ling Leung, Yosef Dicken and 18 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Wheel of p53 Helps to Drive the Immune System.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Not All Immune Checkpoints Are Created Equal.Frontiers in immunology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 5 institutions in 5 countries.

Iris HechtCompugen Ltd., Holon 5885849, Israel; Irish@cgen.com.
Amir ToporikCompugen Ltd., Holon 5885849, Israel.
Joseph R PodojilDepartment of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.ORCID 0000-0002-5818-8515
Ilan VakninCompugen Ltd., Holon 5885849, Israel.
Gady CojocaruCompugen Ltd., Holon 5885849, Israel.
Anat OrenCompugen Ltd., Holon 5885849, Israel.
Elizabeta AizmanCompugen Ltd., Holon 5885849, Israel.
Spencer C LiangCompugen USA Inc., South San Francisco, CA 94080.
Ling LeungCompugen USA Inc., South San Francisco, CA 94080.
Yosef DickenCompugen Ltd., Holon 5885849, Israel.
Amit NovikCompugen Ltd., Holon 5885849, Israel.
Nadav Marbach-BarCompugen Ltd., Holon 5885849, Israel.
Aziza ElmesmariInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, United Kingdom.
Clare TangeInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, United Kingdom.
Ashley GilmourInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, United Kingdom.
Donna McIntyreInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, United Kingdom.
Mariola Kurowska-StolarskaInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, United Kingdom.
Kay McNameeKennedy Institute, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7FY, United Kingdom; and.
Judith LeitnerDivision of Immune Receptors and T Cell Activation, Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Shirley GreenwaldCompugen Ltd., Holon 5885849, Israel.
Liat DassaCompugen Ltd., Holon 5885849, Israel.ORCID 0000-0003-3020-8622
Zurit LevineCompugen Ltd., Holon 5885849, Israel.
Peter SteinbergerDivision of Immune Receptors and T Cell Activation, Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Richard O WilliamsKennedy Institute, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7FY, United Kingdom; and.ORCID 0000-0001-5473-5270
Stephen D MillerDepartment of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.ORCID 0000-0002-9556-0718
Iain B McInnesInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, United Kingdom.
Eyal NeriaCompugen Ltd., Holon 5885849, Israel.
Galit RotmanCompugen Ltd., Holon 5885849, Israel.
Compugen (Israel) · ILInstitute of Infection and Immunity · CAMedical University of Vienna · ATNorthwestern University · USNuffield Orthopaedic Centre · GB

Funding

IMMUNOREGULATION AND PATHOLOGY OF CHRONIC-RELAPSING EAER01NS026543 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MILLER, STEPHEN D · 1988 to 2016
$5.0M
NINDS NIH HHS R01 NS026543
6 · The paper itself

Abstract

The B7-like protein family members play critical immunomodulatory roles and constitute attractive targets for the development of novel therapies for human diseases. We identified Ig-like domain-containing receptor (ILDR)2 as a novel B7-like protein with robust T cell inhibitory activity, expressed in immune cells and in immune-privileged and inflamed tissues. A fusion protein, consisting of ILDR2 extracellular domain with an Fc fragment, that binds to a putative counterpart on activated T cells showed a beneficial effect in the collagen-induced arthritis model and abrogated the production of proinflammatory cytokines and chemokines in autologous synovial-like cocultures of macrophages and cytokine-stimulated T cells. Collectively, these findings point to ILDR2 as a novel negative regulator for T cells, with potential roles in the development of immune-related diseases, including autoimmunity and cancer.

Indexed as

AnimalsB7 AntigensCells, CulturedCytokinesHumansImmunoglobulin DomainsImmunoglobulin Fc FragmentsLymphocyte ActivationMacrophagesMaleMembrane ProteinsMiceMice, Inbred BALB CT-LymphocytesB7 AntigensCytokinesILDR2 protein, mouseImmunoglobulin Fc FragmentsMembrane Proteins

Identifiers

PMID29431694
PMCPMC6860365
OpenAlexW2787858117

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.